vs
Artisan Partners Asset Management Inc.（APAM）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Artisan Partners Asset Management Inc.的1.6倍（$540.7M vs $335.5M），Artisan Partners Asset Management Inc.净利率更高（35.2% vs -2.9%，领先38.1%），Artisan Partners Asset Management Inc.同比增速更快（12.9% vs -14.1%），Artisan Partners Asset Management Inc.自由现金流更多（$171.6M vs $36.0M），过去两年Artisan Partners Asset Management Inc.的营收复合增速更高（12.7% vs -2.3%）
阿蒂森伙伴资产管理公司（Artisan Partners）是总部位于美国威斯康星州密尔沃基的资产管理机构，除美国本土外，还在都柏林、香港、伦敦、新加坡、悉尼设有办公室，为全球客户提供专业的资产管理服务。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
APAM vs ICUI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $335.5M | $540.7M |
| 净利润 | $118.1M | $-15.7M |
| 毛利率 | — | 37.5% |
| 营业利润率 | 39.2% | 1.0% |
| 净利率 | 35.2% | -2.9% |
| 营收同比 | 12.9% | -14.1% |
| 净利润同比 | 34.9% | 34.0% |
| 每股收益（稀释后） | $1.36 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $335.5M | $540.7M | ||
| Q3 25 | $301.3M | $537.0M | ||
| Q2 25 | $282.7M | $548.9M | ||
| Q1 25 | $277.1M | $604.7M | ||
| Q4 24 | $297.1M | $629.8M | ||
| Q3 24 | $279.6M | $589.1M | ||
| Q2 24 | $270.8M | $596.5M | ||
| Q1 24 | $264.4M | $566.7M |
| Q4 25 | $118.1M | $-15.7M | ||
| Q3 25 | $66.8M | $-3.4M | ||
| Q2 25 | $67.6M | $35.3M | ||
| Q1 25 | $61.1M | $-15.5M | ||
| Q4 24 | $87.5M | $-23.8M | ||
| Q3 24 | $73.0M | $-33.0M | ||
| Q2 24 | $57.6M | $-21.4M | ||
| Q1 24 | $59.5M | $-39.5M |
| Q4 25 | — | 37.5% | ||
| Q3 25 | — | 37.4% | ||
| Q2 25 | — | 37.9% | ||
| Q1 25 | — | 34.7% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 34.8% | ||
| Q2 24 | — | 34.8% | ||
| Q1 24 | — | 32.7% |
| Q4 25 | 39.2% | 1.0% | ||
| Q3 25 | 33.8% | 2.6% | ||
| Q2 25 | 28.2% | 1.9% | ||
| Q1 25 | 31.2% | 2.1% | ||
| Q4 24 | 36.7% | 6.0% | ||
| Q3 24 | 33.3% | 1.4% | ||
| Q2 24 | 32.0% | 1.3% | ||
| Q1 24 | 29.4% | -1.9% |
| Q4 25 | 35.2% | -2.9% | ||
| Q3 25 | 22.2% | -0.6% | ||
| Q2 25 | 23.9% | 6.4% | ||
| Q1 25 | 22.1% | -2.6% | ||
| Q4 24 | 29.5% | -3.8% | ||
| Q3 24 | 26.1% | -5.6% | ||
| Q2 24 | 21.3% | -3.6% | ||
| Q1 24 | 22.5% | -7.0% |
| Q4 25 | $1.36 | $-0.63 | ||
| Q3 25 | $0.93 | $-0.14 | ||
| Q2 25 | $0.94 | $1.43 | ||
| Q1 25 | $0.82 | $-0.63 | ||
| Q4 24 | $0.99 | $-0.97 | ||
| Q3 24 | $1.03 | $-1.35 | ||
| Q2 24 | $0.80 | $-0.88 | ||
| Q1 24 | $0.84 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | $190.0M | — |
| 股东权益账面价值 | $438.8M | $2.1B |
| 总资产 | $1.6B | $4.1B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | — | $312.5M | ||
| Q2 24 | — | $302.6M | ||
| Q1 24 | — | $251.4M |
| Q4 25 | $190.0M | — | ||
| Q3 25 | $190.0M | — | ||
| Q2 25 | $200.0M | — | ||
| Q1 25 | $200.0M | — | ||
| Q4 24 | $200.0M | — | ||
| Q3 24 | $200.0M | — | ||
| Q2 24 | $200.0M | — | ||
| Q1 24 | $200.0M | — |
| Q4 25 | $438.8M | $2.1B | ||
| Q3 25 | $402.1M | $2.1B | ||
| Q2 25 | $381.8M | $2.1B | ||
| Q1 25 | $356.5M | $2.0B | ||
| Q4 24 | $388.9M | $2.0B | ||
| Q3 24 | $372.1M | $2.0B | ||
| Q2 24 | $341.2M | $2.0B | ||
| Q1 24 | $320.3M | $2.1B |
| Q4 25 | $1.6B | $4.1B | ||
| Q3 25 | $1.6B | $4.1B | ||
| Q2 25 | $1.4B | $4.1B | ||
| Q1 25 | $1.4B | $4.2B | ||
| Q4 24 | $1.6B | $4.2B | ||
| Q3 24 | $1.6B | $4.3B | ||
| Q2 24 | $1.5B | $4.3B | ||
| Q1 24 | $1.5B | $4.3B |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.59× | — | ||
| Q1 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $172.0M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $171.6M | $36.0M |
| 自由现金流率自由现金流/营收 | 51.2% | 6.6% |
| 资本支出强度资本支出/营收 | 0.1% | 4.6% |
| 现金转化率经营现金流/净利润 | 1.46× | — |
| 过去12个月自由现金流最近4个季度 | $420.6M | $91.8M |
8季度趋势，按日历期对齐
| Q4 25 | $172.0M | $60.6M | ||
| Q3 25 | $40.4M | $56.7M | ||
| Q2 25 | $50.9M | $11.2M | ||
| Q1 25 | $157.9M | $51.3M | ||
| Q4 24 | $372.8M | $40.2M | ||
| Q3 24 | $112.8M | $36.1M | ||
| Q2 24 | $75.9M | $82.0M | ||
| Q1 24 | $147.0M | $45.8M |
| Q4 25 | $171.6M | $36.0M | ||
| Q3 25 | $40.4M | $27.6M | ||
| Q2 25 | $50.9M | $-8.5M | ||
| Q1 25 | $157.7M | $36.7M | ||
| Q4 24 | $371.3M | $16.1M | ||
| Q3 24 | $112.4M | $16.2M | ||
| Q2 24 | $75.2M | $62.5M | ||
| Q1 24 | $146.9M | $29.9M |
| Q4 25 | 51.2% | 6.6% | ||
| Q3 25 | 13.4% | 5.1% | ||
| Q2 25 | 18.0% | -1.5% | ||
| Q1 25 | 56.9% | 6.1% | ||
| Q4 24 | 125.0% | 2.6% | ||
| Q3 24 | 40.2% | 2.7% | ||
| Q2 24 | 27.8% | 10.5% | ||
| Q1 24 | 55.6% | 5.3% |
| Q4 25 | 0.1% | 4.6% | ||
| Q3 25 | 0.0% | 5.4% | ||
| Q2 25 | 0.0% | 3.6% | ||
| Q1 25 | 0.1% | 2.4% | ||
| Q4 24 | 0.5% | 3.8% | ||
| Q3 24 | 0.1% | 3.4% | ||
| Q2 24 | 0.2% | 3.3% | ||
| Q1 24 | 0.0% | 2.8% |
| Q4 25 | 1.46× | — | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 0.75× | 0.32× | ||
| Q1 25 | 2.58× | — | ||
| Q4 24 | 4.26× | — | ||
| Q3 24 | 1.54× | — | ||
| Q2 24 | 1.32× | — | ||
| Q1 24 | 2.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APAM
暂无分部数据
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
